Fluoxetine (Prozac) interaction with the mitochondrial voltage‐dependent anion channel and protection against apoptotic cell death

The mitochondrial permeability transition pore and its role in cell death

CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432 · see citing works

The mitochondrial permeability transition

Zoratti, M., & Szabó, I. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00003-a · Cited by 2,395 · see citing works

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178 · see citing works

Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication

Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647 · see citing works

VDAC: The channel at the interface between mitochondria and the cytosol

Colombini, M. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009862.17396.8d · Cited by 500 · see citing works

In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death

AZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., & SHOSHAN-BARMATZ, V. (2004) · Biochemical Journal · doi:10.1042/bj20031465 · Cited by 408 · see citing works

Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function

GINCEL, D., ZAID, H., & SHOSHAN-BARMATZ, V. (2001) · Biochemical Journal · doi:10.1042/bj3580147 · Cited by 396 · cited 6× · see citing works

Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function

Gincel, D., Zaid, H., & Shoshan‐Barmatz, V. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580147 · Cited by 396 · see citing works

Essential Role of Voltage-Dependent Anion Channel in Various Forms of Apoptosis in Mammalian Cells

Shimizu, S., Matsuoka, Y., Shinohara, Y., Yoneda, Y., & Tsujimoto, Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.237 · Cited by 367 · see citing works

VDAC channels mediate and gate the flow of ATP: implications for the regulation of mitochondrial function

Rostovtseva, T. K., & Colombini, M. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78841-6 · Cited by 357 · see citing works

Inhibition of Neuronal Na+ Channels by Antidepressant Drugs

Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K., & Lynch, C. I. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37206-4 · Cited by 311 · see citing works

The voltage-dependent anion channel-1 modulates apoptotic cell death

Zaid, H., Abu‐Hamad, S., Israelson, A., Nathan, I., & Shoshan‐Barmatz, V. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401599 · Cited by 299 · see citing works

Regulation of Metabolite Flux through Voltage-Gating of VDAC Channels

Hodge, T., & Colombini, M. (1997) · The Journal of Membrane Biology · doi:10.1007/s002329900235 · Cited by 281 · see citing works

Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.

Brandes, L. J., Arron, R. J., Bogdanovic, R. P., TONG, J. J., Zaborniak, C. L., Hogg, G. R., Warrington, R. C., Fang, W., & LaBella, F. S. (1992) · PubMed · Cited by 211 · see citing works

Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats

Lee, H. J., Kim, J. W., Yim, S. V., Kim, M. J., Kim, S. A., Kim, Y. J., Kim, C., & Chung, J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000947 · Cited by 205 · see citing works

Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide

Zheng, Y., Shi, Y., Tian, C., Jiang, C., Jin, H., Chen, J., Almasan, A., Tang, H., & Chen, Q. (2003) · Oncogene · doi:10.1038/sj.onc.1207205 · Cited by 202 · see citing works

Fluoxetine, a selective inhibitor of serotonin uptake

Fuller, R. W., Wong, D. T., & Robertson, D. W. (1991) · Medicinal Research Reviews · doi:10.1002/med.2610110103 · Cited by 197 · see citing works

Inhibition of apoptosis as a mechanism of tumor promotion

Wright, S. C., Zhong, J., & Larrick, J. W. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.9.8005393 · Cited by 196 · see citing works

Side-Effect Profile of Fluoxetine in Comparison with Other SSRIs, Tricyclic and Newer Antidepressants: A Meta-Analysis of Clinical Trial Data

Brambilla, P., Cipriani, A., Hotopf, M., & Barbui, C. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837806 · Cited by 181 · see citing works

Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells

Serafeim, A., Holder, M. J., Grafton, G., Chamba, A., Drayson, M. T., Luong, Q. T., Bunce, C. M., Gregory, C. D., Barnes, N. M., & Gordon, J. (2003) · Blood · doi:10.1182/blood-2002-07-2044 · Cited by 174 · see citing works

MDMA (Ecstasy) Inhibition of MAO Type A and Type B: Comparisons with Fenfluramine and Fluoxetine (Prozac)

Leonardi, E. T. K., & Azmitia, E. C. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.26 · Cited by 162 · see citing works

The voltage-dependent anion channel

Shoshan-Barmatz, V., & Gincel, D. (2007) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:39:3:279 · Cited by 158 · see citing works

Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)

García‐Colunga, J., AWAD, J., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2041 · Cited by 149 · see citing works

Antidepressant Medication Use and Breast Cancer Risk

Cotterchio, M., Kreiger, N., Darlington, G., & Steingart, A. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010138 · Cited by 132 · see citing works

Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells

Deák, F., Lasztóczi, B., Pacher, P., Petheö, G. L., Kecskeméti, V., & Spät, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00206-3 · Cited by 124 · see citing works

Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli

Elinder, F., Akanda, N., Tofighi, R., Shimizu, S., Tsujimoto, Y., Orrenius, S., & Ceccatelli, S. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401646 · Cited by 119 · see citing works

The Voltage-dependent Anion Channel Is the Target for a New Class of Inhibitors of the Mitochondrial Permeability Transition Pore

Cesura, A. M., Pinard, E., Schubenel, R., Goetschy, V., Friedlein, A., Langen, H., Polčic, P., Forte, M. A., Bernardi, P., & Kemp, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304748200 · Cited by 107 · see citing works

Fluoxetine Inhibits Multidrug Resistance Extrusion Pumps and Enhances Responses to Chemotherapy in Syngeneic and in Human Xenograft Mouse Tumor Models

Peer, D., Dekel, Y., Melikhov, D., & Margalit, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4046 · Cited by 99 · see citing works

Fluoxetine increases the content of neurotrophic protein S100β in the rat hippocampus

Manev, R. M., Uz, T., & Manev, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00989-x · Cited by 87 · see citing works

Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity

Curti, C., Mingattao, F. E., Polizello, A. C. M., Galastri, L. O., Uyemura, S. A., & Santos, A. C. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006912010550 · Cited by 74 · see citing works

VDAC and peripheral channelling complexes in health and disease

Vyssokikh, M. Y., & Brdiczka, D. G. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009863.69249.d9 · Cited by 55 · see citing works

Antidepressant use and the risk of breast cancer

Wang, P. S., Walker, A. M., Tsuang, M. T., Orav, E. J., Levin, R., & Avorn, J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00354-1 · Cited by 55 · see citing works

Glutamate Interacts with VDAC and Modulates Opening of the Mitochondrial Permeability Transition Pore

Gincel, D., & Shoshan‐Barmatz, V. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000023621.72873.9e · Cited by 53 · see citing works

Evaluation of the binding of the radiolabeled antidepressant drug, 18F-fluoxetine in the rodent brain: an in vitro and in vivo study

Mukherjee, J., Das, M. K., Yang, Z.-Y., & Lew, R. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00043-2 · Cited by 47 · see citing works

Does fluoxetine (Prozak) block mitochondrial permeability transition by blocking VDAC as part of permeability transition pores?

THINNES, F. P. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.12.008 · Cited by 19 · see citing works

VDAC, a multi-functional mitochondrial protein regulating cell life and death

Shoshan‐Barmatz, V., Pinto, V. D., Zweckstetter, M., Raviv, Z., Keinan, N., & Arbel, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.03.002 · Cited by 792 · see citing works

The mitochondrial permeability transition from<i>in vitro</i>artifact to disease target

Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blalchy‐Dyson, E., Di Lisa, F., & Forte, M. A. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05213.x · Cited by 627 · see citing works

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders

Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 334 · see citing works

Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders

Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333 · see citing works

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325 · see citing works

VDAC, a multi-functional mitochondrial protein as a pharmacological target

Shoshan‐Barmatz, V., & Ben-Hail, D. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.04.001 · Cited by 250 · see citing works

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205 · see citing works

The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression

Shu, X., Sun, Y., Sun, X., Zhou, Y., Bian, Y., Shu, Z., Ding, J., Lu, M., & Hu, G. (2019) · Cell Death &amp; Disease · doi:10.1038/s41419-019-1813-9 · Cited by 203 · see citing works

VDAC1: from structure to cancer therapy

Shoshan‐Barmatz, V., & Mizrachi, D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00164 · Cited by 193 · see citing works

VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis

Magrì, A., Reina, S., & Pinto, V. D. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00108 · Cited by 179 · see citing works

A mitochondrial bioenergetic basis of depression

Klinedinst, N. J., & Regenold, W. T. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9584-6 · Cited by 153 · see citing works

Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy

Shoshan‐Barmatz, V., & Golan, M. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712798992110 · Cited by 139 · see citing works

“Killing the Blues”: A role for cellular suicide (apoptosis) in depression and the antidepressant response?

McKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 138 · see citing works

Nanotechnology inspired tools for mitochondrial dysfunction related diseases

Wen, R. M., Banik, B., Pathak, R., Kumar, A., Kolishetti, N., & Dhar, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.024 · Cited by 130 · see citing works

Fluoxetine Increases Hippocampal Neurogenesis and Induces Epigenetic Factors But Does Not Improve Functional Recovery after Traumatic Brain Injury

Wang, Y., Neumann, M., Hansen, K., Hong, S. M., Kim, S. H., Noble‐Haeusslein, L. J., & Liu, J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1648 · Cited by 102 · see citing works

Therapeutic Potential of Fluoxetine in Neurological Disorders

Mostert, J. P., Koch, M. W., Heerings, M. A. P., Heersema, D. J., & Keyser, J. D. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00040.x · Cited by 101 · see citing works

Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell

Chiou, S., Chen, S., Peng, C., Chang, Y.-L., Ku, H., Hsu, W., Ho, L. L.-T., & Lee, C.-H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.180 · Cited by 96 · see citing works

Inflammation and Depression: Why Poststroke Depression may be the Norm and Not the Exception

Pascoe, M. C., Crewther, S. G., Carey, L. M., & Crewther, D. P. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00565.x · Cited by 94 · see citing works

Fluoxetine and the mitochondria: A review of the toxicological aspects

de Oliveira, M. R. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.07.001 · Cited by 96 · see citing works

Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.

Drzyzga, Ł., Marcinowska, A., & Obuchowicz, E. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.03.009 · Cited by 92 · see citing works

In vitro inhibition of mitochondrial respiratory rate by antidepressants

Hroudová, J., & Fišar, Z. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.017 · Cited by 85 · see citing works

Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

Yue, J. K., Burke, J., Upadhyayula, P. S., Winkler, E. A., Deng, H., Robinson, C. K., Pirracchio, R., Suen, C. G., Sharma, S., Ferguson, A. R., et al. (2017) · Brain Sciences · doi:10.3390/brainsci7080093 · Cited by 75 · see citing works

Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline

Wann, B. P., Bah, T. M., Kaloustian, S., Boucher, M., Dufort, A., Marec, N. L., Godbout, R., & Rousseau, G. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089820 · Cited by 73 · see citing works

Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention

Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 70 · see citing works

A Role for Voltage-Dependent Anion Channel Vdac1 in Polyglutamine-Mediated Neuronal Cell Death

Ghosh, T., Pandey, N., Maitra, A., Brahmachari, S. K., & Pillai, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001170 · Cited by 63 · see citing works

Mitochondrial dysfunction bridges negative affective disorders and cardiomyopathy in socially isolated rats: Pros and cons of fluoxetine

Sonei, N., Amiri, S., Jafarian, I., Anoush, M., Rahimi-Balaei, M., Bergen, H., Haj‐Mirzaian, A., & Hosseini, M. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1149218 · Cited by 59 · see citing works

Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression

Wann, B. P., Bah, T. M., Boucher, M., Courtemanche, J., Marec, N. L., Rousseau, G., & Godbout, R. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0702 · Cited by 60 · see citing works

Ion transfer stripping voltammetry for the detection of nanomolar levels of fluoxetine, citalopram, and sertraline in tap and river water samples

Izadyar, A., Arachchige, D. R., Cornwell, H., & Hershberger, J. C. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.09.048 · Cited by 58 · see citing works

Pharmacological modulation of mitochondrial ion channels

Leanza, L., Checchetto, V., Biasutto, L., Rossa, A., Costa, R., Bachmann, M., Zoratti, M., & Szabó, I. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14544 · Cited by 50 · see citing works

Mechanisms of antidepressant action: An integrated dopaminergic perspective

Porcelli, S., Drago, A., Fabbri, C., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.005 · Cited by 49 · see citing works

Fluoxetine Upregulates Phosphorylated-AKT and Phosphorylated-ERK1/2 Proteins in Neural Stem Cells: Evidence for a Crosstalk between AKT and ERK1/2 Pathways

Huang, W. C., Zhao, Y. C., Zhu, X., Cai, Z., Wang, S., Yao, S., Qi, Z., & Xie, P. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9822-5 · Cited by 47 · see citing works

Proteomic characterization of hippocampus of chronically socially isolated rats treated with fluoxetine: Depression-like behaviour and fluoxetine mechanism of action

Perić, I., Costina, V., Stanisavljević, A., Findeisen, P., & Filipović, D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.034 · Cited by 47 · see citing works

Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria

Filipović, D., Costina, V., Perić, I., Stanisavljević, A., & Findeisen, P. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.025 · Cited by 46 · see citing works

Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?

Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42 · see citing works

Neuroprotective Effect of Apigenin on Depressive-Like Behavior: Mechanistic Approach

Bijani, S., Dizaji, R., Sharafi, A., & Hosseini, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03473-0 · Cited by 42 · see citing works

A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease

Benek, O., Aitken, L., Hroch, L., Kuča, K., Gunn‐Moore, F. J., & Musílek, K. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163051 · Cited by 41 · see citing works

Fluorometric study of fluoxetine DNA binding

Kashanian, S., Javanmardi, S., Chitsazan, A., Paknejad, M., & Omidfar, K. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.04.002 · Cited by 40 · see citing works

Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome

Zhang, C., Wu, Z., Hong, W., Wang, Z., Peng, D., Chen, J., Yuan, C., Yu, S., Xu, L., & Fang, Y. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.010 · Cited by 38 · see citing works

Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents

Chilmończyk, Z., Bojarski, A. J., Pilc, A., & Sylte, I. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.011 · Cited by 31 · see citing works

Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection

Steiner, J. P., Bachani, M., Wolfson-Stofko, B., Lee, M., Wang, T., Li, G., Li, W., Strayer, D. S., Haughey, N. J., & Nath, A. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0315-9 · Cited by 30 · see citing works

New Perspectives for the Rescue of Cognitive Disability in Down Syndrome

Bartesaghi, R., Haydar, T. F., Delabar, J. M., Dierssen, M., Martínez‐Cué, C., & Bianchi, D. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2775-15.2015 · Cited by 32 · see citing works

Fluoxetine pretreatment enhances neurogenic, angiogenic and immunomodulatory effects of MSCs on experimentally induced diabetic neuropathy

Abdelrahman, S. A., Samak, M. A., & Shalaby, S. M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2838-6 · Cited by 29 · see citing works

The Predominant Protective Effect of Tianeptine Over Other Antidepressants in Models of Neuronal Apoptosis: The Effect Blocked by Inhibitors of MAPK/ERK1/2 and PI3-K/Akt Pathways

Jantas, D., Krawczyk, S., & Lasoń, W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9430-3 · Cited by 29 · see citing works

Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex

Djordjevic, A. D., Djordjevic, J., Elaković, I., Adžić, M., Matić, G. M., & Radojcic, M. B. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.042 · Cited by 27 · see citing works

Targeting Mitochondrial Ion Channels to Fight Cancer

Bachmann, M., Costa, R., Peruzzo, R., Prosdocimi, E., Checchetto, V., & Leanza, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072060 · Cited by 27 · see citing works

Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?

Ben‐Shachar, D., & Ene, H. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.007 · Cited by 26 · see citing works

The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity

Morén, C., Juárez‐Flores, D. L., Cardellach, F., & Garrabou, G. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160322143631 · Cited by 25 · see citing works

News about VDAC1 in Hypoxia

Mazure, N. M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00193 · Cited by 25 · see citing works

Protective effects of melatonin on long-term administration of fluoxetine in rats

Khaksar, M., Oryan, A., Sayyari, M., Rezabakhsh, A., & Rahbarghazi‬, R. (2017) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2017.05.002 · Cited by 25 · see citing works

Editor’s Highlight: Therapeutic Concentrations of Antidepressants Inhibit Pancreatic Beta-Cell Function via Mitochondrial Complex Inhibition

Elmorsy, E. M., Al-Ghafari, A. B., Helaly, A. M., Hisab, A. S., Oehrle, B., & Smith, P. A. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx090 · Cited by 24 · see citing works

The neurodegenerative hypothesis of depression and the influence of antidepressant medications

Hall, S., Parr, B.-A., Hussey, S., Anoopkumar‐Dukie, S., Arora, D. S., & Grant, G. D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176967 · Cited by 24 · see citing works

Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications

Lauterbach, E. C., Shillcutt, S. D., Victoroff, J., Coburn, K. L., & Mendez, M. F. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.2.130 · Cited by 21 · see citing works

Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects

Sołek, P., Mytych, J., Tabęcka-Łonczyńska, A., & Koziorowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111855 · Cited by 21 · see citing works

Mitochondrial ion channels in pancreatic β‐cells: Novel pharmacological targets for the treatment of Type 2 diabetes

Marchi, U. D., Fernandez‐Martinez, S., de la Fuente, S., Wiederkehr, A., & Domingo, J. S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15018 · Cited by 20 · see citing works

Approaching the structure of human VDAC1, a key molecule in mitochondrial cross-talk

Zeth, K., Meins, T., & Vonrhein, C. (2008) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-008-9144-z · Cited by 19 · see citing works

Effects of amitriptyline and fluoxetine on synaptic plasticity in the dentate gyrus of hippocampal formation in rats

Reisi, P., Zarei, G., Alaei, H., & Javanmard, S. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.142044 · Cited by 18 · see citing works

Serotonin transporter inhibition during neonatal period induces sex‐dependent effects on mitochondrial bioenergetics in the rat brainstem

Silva, T. L. A., Braz, G. R. F., Silva, S. C. D. A., Pedroza, A. A. D. S., Freitas, C. D. M., Ferreira, D. J. S., da Silva, A. I., & Lagranha, C. J. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13971 · Cited by 17 · see citing works

Inhibition by fluoxetine of LH-stimulated cyclic AMP synthesis in tumor Leydig cells partly involves AMPK activation

Nguyen, T. M. D., Klett, D., Filliatreau, L., & Combarnous, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217519 · Cited by 16 · see citing works

Expression Profiles of Mitochondrial Genes in the Frontal Cortex and the Caudate Nucleus of Developing Humans and Mice Selectively Bred for High and Low Fear

Choi, K. H., Le, T., McGuire, J. L., Coyner, J. L., Higgs, B. W., Diglisic, S., Johnson, L. R., Benedek, D. M., & Ursano, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049183 · Cited by 15 · see citing works

Increased cellular turnover in response to fluoxetine in neuronal precursors derived from human embryonic stem cells

Chang, E.-A., Beyhan, Z., Yoo, M.-S., Siripattarapravat, K., Ko, T., Lookingland, K. J., Madhukar, B. V., & Cibelli, J. B. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092851ec · Cited by 15 · see citing works

New findings concerning vertebrate porin II — On the relevance of glycine motifs of type-1 VDAC

THINNES, F. P. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.01.008 · Cited by 14 · see citing works

Quinidine partially blocks mitochondrial voltage-dependent anion channel (VDAC)

Malik, C., & Ghosh, S. (2020) · European Biophysics Journal · doi:10.1007/s00249-020-01426-z · Cited by 14 · see citing works

Intracellular Calcium Homeostasis and Kidney Disease

Song, N., Yang, M., Zhang, H., & Yang, S. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201102114257 · Cited by 14 · see citing works

Effects of fluoxetine on cloned Kv4.3 potassium channels

Jeong, I., Choi, J., & Hahn, S. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.028 · Cited by 14 · see citing works

Combining nano-differential scanning fluorimetry and microscale thermophoresis to investigate VDAC1 interaction with small molecules

Gorny, H., Mularoni, A., Delcros, J., Freton, C., Preto, J., & Krimm, I. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2121821 · Cited by 14 · see citing works

Synthetic Ubiquinones Specifically Bind to Mitochondrial Voltage-Dependent Anion Channel 1 (VDAC1) in Saccharomyces cerevisiae Mitochondria

Murai, M., Okuda, A., Yamamoto, T., Shinohara, Y., & Miyoshi, H. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01011 · Cited by 13 · see citing works

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Bockstaele, E. J. V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6 · Cited by 13 · see citing works

Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats

Nahas, Z. H., JIANG, Y., Zeidan, Y. H., Bielawska, A. E., Szulc, Z. M., DeVane, L., Kalivas, P. W., & Hannun, Y. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.07.040 · Cited by 12 · see citing works

Small-Molecule Modulators of Mitochondrial Channels as Chemotherapeutic Agents

Parrasia, S., Mattarei, A., Furlan, A., Zoratti, M., & Biasutto, L. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000192 · Cited by 12 · see citing works

Enantiomeric separation of antidepressant drug fluoxetine based on chiral membranes

Salgın, S., Salgın, U., & Tuzlalı, N. (2018) · Desalination and Water Treatment · doi:10.5004/dwt.2018.22130 · Cited by 12 · see citing works

Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCδ-Mediated Mitochondrial Dysfunction

Shin, E., Jeong, J. H., Nguyen, B.-T., Sharma, N., Nah, S.-Y., Chung, Y. H., Lee, Y., Byun, J. K., Nabeshima, T., Ko, S. K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137219 · Cited by 11 · see citing works

Shared and unique transcriptomic signatures of antidepressant and probiotics action in the mammalian brain

Rayan, N. A., Aow, J., Lim, M. G. L., Arcego, D. M., Ryan, R., Nourbakhsh, N., de Lima, R. M. S., Craig, K., Zhang, T., Goh, Y. T., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02619-0 · Cited by 10 · see citing works

Post-Myocardial Infarction Depression

Rousseau, G., Bah, T. M., & Godbout, R. (2012) · InTech eBooks · doi:10.5772/33408 · Cited by 10 · see citing works

Early Gβγ-GRK2 Inhibition Ameliorates Osteoarthritis Development by Simultaneous Anti-Inflammatory and Chondroprotective Effects

Karuppagounder, V., Pinamont, W. J., Yoshioka, N. K., Elbarbary, R. A., & Kamal, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147933 · Cited by 8 · see citing works

Fluoxetine Induces Apoptotic and Oxidative Neuronal Death Associated with The Influx of Copper Ions in Cultured Neuronal Cells

Hwang, S., & Kim, J.-K. (2020) · Chonnam Medical Journal · doi:10.4068/cmj.2020.56.1.20 · Cited by 8 · see citing works

Regulation of Single-Channel Conductance of Voltage-Dependent Anion Channel by Mercuric Chloride in a Planar Lipid Bilayer

Malik, C., & Ghosh, S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00134-1 · Cited by 8 · see citing works

Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells

Wang, Y., Hilton, B., Cui, K., & Zhu, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9534-z · Cited by 8 · see citing works

The Rhizome of Trillium tschonoskii Maxim. Extract Induces Apoptosis in Human Lung Cancer Cells

Huang, W., Zou, K., & Xiong, B. (2011) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2011-9-1007 · Cited by 7 · see citing works

Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers

Fišar, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_6 · Cited by 7 · see citing works

Mitochondrial Dysfunction and Oxidative Stress: Relevance to the Pathophysiology and Treatment of Depression

Lopresti, A. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00015-9 · Cited by 6 · see citing works

Colorimetric recognition of fluoxetine and sertraline using citrate-capped gold nanoparticles

Laghari, S., & Khuhawar, M. Y. (2023) · Chemical Papers · doi:10.1007/s11696-023-02990-2 · Cited by 5 · see citing works

Fluoxetine affects cytosolic cAMP, ATP, Ca2+ responses to forskolin, and survival of human ovarian granulosa tumor COV434 cells

Nguyen, T. M. D., Klett, D., & Combarnous, Y. (2021) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2021.25.3.189 · Cited by 5 · see citing works

Dopaminergic system: stress, depression, cancer (part 1)

Bocharova, O. A., Бочаров, Е. В., Kucheryanu, V. G., & Карпова, Р. В. (2019) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2019-18-3-6-14 · Cited by 3 · see citing works

Ameliorated Neurogenesis Deficits in Dentate Gyrus May Underly the Pronounced Antidepressant Effect of TREK-1 Potassium Channel Blockade in Rats with Depressive-like Behavior

Xu, H., Ding, Y., Qi, X., Zhang, Z., & Su, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00428 · Cited by 2 · see citing works

Fluoxetine Alters the Biophysics of DPPC and DPPG Bilayers through Phase-Dependent and Electrostatic Interactions

Ho, T. H., Tran, K. G., Huynh, L. K., & Nguyen, T. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c04631 · Cited by 1 · see citing works

Depression: Current Conceptual Trends

Nahas, Z. H. (2016) · Springer eBooks · doi:10.1007/978-1-59745-495-7_1 · Cited by 1 · see citing works

The effects of fluoxetine and quetiapine on the proliferation and differentiation of, and GDNF release from, C6 cells

Shen, L. (2006) · University Library - University of Saskatchewan (University of Saskatchewan)

Selective Serotonin Reuptake Inhibitors (SSRIs) and Breast Cancer: A Record Linkage Study

Ashbury, J. E. (2008)

At the Crossroads Between Mitochondrial Metabolite Transport and Apoptosis: VDAC1 as an Emerging Cancer Drug Target

Shoshan‐Barmatz, V., Shteinfer‐Kuzmine, A., Ben-Hail, D., Arif, T., & Mizrachi, D. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_16

Drug‐Induced Mitochondrial Toxicity during Pregnancy

Juárez‐Flores, D. L., Hernández, A. S., García‐Otero, L., Guitart‐Mampel, M., Catalán‐García, M., González‐Casacuberta, I., Milisenda, J. C., Grau, J. M., Cardellach, F., Morén, C., et al. (2018) · doi:10.1002/9781119329725.ch33

Functional facets of dopaminergic system and cancer. Part 1

Bocharov, E. V., Кучеряну, В. Г., & Bocharova, O. A. (2017) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2017.03.116-126

. Effect of fluoxetine on the inhibition of adenylate cyclase activity in foskolin-stimulated MLTC-1 leydig cells

Nguyen, T. M. D., Hằng, N. T., Minh, N. L. C., Sơn, T. T., & Dương, N. T. (2020) · Vietnam Journal of Biotechnology · doi:10.15625/1811-4989/17/4/14743

Author Index

(2005) · FEBS Letters · doi:10.1016/s0014-5793(05)01501-2

Gβγ-GRK2 inhibition ameliorates synovitis and pathological macrophage activation in murine post-traumatic osteoarthritisPreprint

Karuppagounder, V., Pinamont, W. J., Yoshioka, N. K., Elbarbary, R. A., & Kamal, F. (2022) · doi:10.22541/au.164873432.28611937/v1

Effect of fluoxetine on cyclic adenosine monophosphate response to follicle-stimulating hormone in HEK cells

Nguyen, T. M. D., & Nguyen, T. M. D. (2022) · Veterinary Integrative Sciences · doi:10.12982/vis.2022.056

Fluoxetine as an antidepressant agent induces directly deleterious effects on rat isolated pancreatic mitochondria: ameliorative role of betanin

Salimi, A., Khezri, S., Azami, A. M., Ayremlou, S. T., & Adhami, V. (2025) · Xenobiotica · doi:10.1080/00498254.2025.2564120

Selective serotonin reuptake inhibitors and tricyclic antidepressants : novel immunomodulating agents

Gordon, S. (2012) · University of Brighton Repository (University of Brighton)

Fluoxetine reprograms hippocampal mitochondrial subcellular proteomes in chronically socially isolated rats

Pajović, S., & Filipović, D. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0152

Subchronic exposure to environmental levels of fluoxetine disturbs gut microbiota-mediated intestinal barrier homeostasis and triggers delayed feeding response in zebrafish (Danio rerio)

Lu, L., Pan, C., Fu, L., Zhao, L., Wang, H.-Y., Yao, W., & Yang, M. (2026) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2026.110551

Does fluoxetine (Prozak) block mitochondrial permeability transition by blocking VDAC as part of permeability transition pores?

THINNES, F. P. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.12.008 · Cited by 19 · see citing works

Fluoxetine and the mitochondria: A review of the toxicological aspects

de Oliveira, M. R. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.07.001 · Cited by 96 · see citing works

Progress in voltage-dependent anion channels in mitochondria-dependent apoptosis

Zhong, C. (2011) · Zhongguo yaolixue yu dulixue zazhi

Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)

Tytgat, J., Maertens, C., & Daenens, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701545 · Cited by 79 · see citing works

The antidepressant fluoxetine induces necrosis by energy depletion and mitochondrial calcium overload

Charles, E. M., Hammadi, M., Kischel, P., Delcroix, V., Demaurex, N., Castelbou, C., Vacher, A.-M., Devin, A., Ducret, T., Nunes, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13689 · Cited by 49 · see citing works